# Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

> **NCT00000678** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 320 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zidovudine
- **DRUG:** Zalcitabine

## Key facts

- **NCT ID:** NCT00000678
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 1992-07
- **Final completion:** —
- **Target enrollment:** 320 (—)
- **Last updated:** 2011-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000678, "Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*